Clinical Cancer Research CR Helping Patients AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Clinical Cancer Research 14, 627, February 1, 2008. doi: 10.1158/1078-0432.CCR-07-2220
© 2008 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parsons, J. T.
Right arrow Articles by Roberts, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parsons, J. T.
Right arrow Articles by Roberts, W. G.

Molecular Pathways

Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention

J. Thomas Parsons1, Jill Slack-Davis1, Robert Tilghman1 and W. Gregory Roberts2

Authors' Affiliations: 1 Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia and 2 Pfizer Oncology, Groton, Connecticut

Requests for reprints: J. Thomas Parsons, Department of Microbiology, University of Virginia Health System, P.O. Box 800734, Charlottesville, VA 22908. Phone: 434-924-5395; Fax: 434-982-1071; E-mail: jtp{at}virginia.edu.

Abstract

The tumor microenvironment plays a central role in cancer progression and metastasis. Within this environment, cancer cells respond to a host of signals including growth factors and chemotactic factors, as well as signals from adjacent cells, cells in the surrounding stroma, and signals from the extracellular matrix. Targeting the pathways that mediate many of these signals has been a major goal in the effort to develop therapeutics.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
E. R. Siu, E. W. P. Wong, D. D. Mruk, C. S. Porto, and C. Y. Cheng
Focal adhesion kinase is a blood-testis barrier regulator
PNAS, June 9, 2009; 106(23): 9298 - 9303.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Schwock, N. Dhani, M. P.-J. Cao, J. Zheng, R. Clarkson, N. Radulovich, R. Navab, L.-C. Horn, and D. W. Hedley
Targeting Focal Adhesion Kinase with Dominant-Negative FRNK or Hsp90 Inhibitor 17-DMAG Suppresses Tumor Growth and Metastasis of SiHa Cervical Xenografts
Cancer Res., June 1, 2009; 69(11): 4750 - 4759.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. C Smallridge, L. A Marlow, and J. A Copland
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.